OncoMed Pharmaceuticals Inc: cashflow_investing

Value{"amount": 41182000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2018-01-01 – 2018-12-31
Statuscurrent
EntityOncoMed Pharmaceuticals Inc
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-19-006795 · Open the official SEC filing →
Retrieved: 2026-08-19T12:24:59.902707+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001302573/cashflow-investing/2018-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4cc4cfd5-be4e-4535-b220-b39e666d1623

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies